Global Cerium Oxide Nanoparticles TOC
APAC Market Forecasts
The cerium oxide nanoparticles market revenue in Asia Pacific excluding Japan is predicted to surpass USD 3.01 billion in the year 2036, up from a revenue of USD 290.1 million in the year 2022. The growing prevalence of cardiovascular disease is expected to drive the market revenue in this region. For instance, in India, the number of deaths from heart attacks has remained consistently higher than 24,999 in the last four years, and more than 27,999 in the last three years. Nanomaterials are now able to be utilized to treat heart conditions due to developments in nanomedicine. The irreversible oxidative states of cerium oxide nanoparticles, Ce3+ & Ce4+, which provide them special physiologically significant features including antioxidant properties, anti-inflammatory properties, free radical scavenging capabilities, and more are gaining attention in this region.
North American Market Statistics
The North America cerium oxide nanoparticles market is expected to have notable growth during the forecast period. The region has a significant biomedical industry, that is growing as a result of an increase in the number of elderly people, rising R&D spending, and the demand for cutting-edge cures and treatments. Cerium oxide nanoparticles have attracted a lot of attention from the biomedical industry due to their exceptional antioxidant properties. Therefore, this factor is estimated to dominate the cerium oxide nanoparticles market expansion in this region.
Author Credits: Rajrani Baghel
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?